Catalyst Wire Dossier Catalyst Wire Dossier

Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid

umbilical cord mesenchymal stem cells with hyaluronic acid filler
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid, covering 2016-03-04 to 2016-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid [Phase 1]

See pricing